Dr Elizabeth Kpozehouen

Elizabeth is a medical doctor trained in China; she has completed, Master of Public Health, Master of Health Management and PhD in Public Health programs at UNSW. Dr Kpozehouen has over 12 years of experience in infectious disease epidemiology research and project management. Elizabeth has experience working as a research associate and project manager at the NHMRC Centre of Research Excellence (CRE) in - Immunisation in understudied and special risk populations and CRE in Integrated Systems for Epidemic Response at UNSW. She has published seven peer-reviewed papers on vaccinology as the first author.

In the past 6 years, Dr  Kpozehouen has done research on patient and provider determinants of vaccination in people with cardiovascular disease. She has experience as a clinical trial coordinator for a multi-country randomised clinical trial, “Influenza vaccination after Myocardial Infarction” (IAMI trial), the first and largest RCT to evaluate the effect of in-hospital influenza vaccination on death and cardiovascular outcomes in patients with myocardial infarction. She has published 5 peer-reviewed papers on determinants of vaccination in people with cardiovascular disease as the first author.

She currently works as a Research Associate for the Epiwatch. This AI-driven open-source outbreak observatory captures early epidemic signals globally and rapid epidemic detection. She has published one peer-reviewed paper on artificial intelligence as the first author. Elizabeth also works as a research associate for a randomised clinical trial, “Bushfire smoke, asthma, lung disease and masks (BREATHE trial)”.